Oral Eruption Associated With Cefuroxime Axetil: An Unusual Complication

Authors

  • Himanshu Bhusan Sahoo
  • Bandana Rath
  • Jayanti Prava Behera
  • Chandra Sekhar Moharana

DOI:

https://doi.org/10.37591/rrjohp.v5i3.880

Abstract

Cefuroxime Axetil is an oral cephalosporin class of antibiotic having broader gram negative activity and used in infective conditions caused by facultative bacteria and anaerobes such as respiratory tract infection, intra-abdominal infection, pelvic inflammatory disease and diabetic foot infection etc. Severe oral eruption associated with swelling on lips and mucosal erythemas are not described previously as ADR due to Cefuroxime. Here, we report a case of severe oral eruption induced by Cefuroxime Axetil. An adult male of 27 y of age received Cefuroxime Axetil with Paracetamol tablet for upper respiratory tract infection. Three days after ingestion of the above drugs, the patient developed severe oral eruption associated with swelling on lips, mucosal erythema and multiple whitish spots on face. This case was managed by withdrawal of cefuroxime with symptomatic therapy. Thus, it is important to recognize such type of reaction and manage it to prevent fatality.

 

Keywords: Cefuroxime Axetil, paracetamol, respiratory tract infection, oral eruption, mucosal erythema

 

Cite this Article

Himanshu Bhusan Sahoo, Bandana Rath, Jayanti Prava Behera et al. Oral eruption associated with cefuroxime axetil: an unusual complication. Research & Reviews: Journal of Health Professions. 2015; 5(3): 16–18p.

Downloads

Published

2019-03-22

Issue

Vol. 5 No. 3 (2015)

Section

Case Study

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.